- Article number:
- 1672-0571(2024)04-0070-05
- ZTFLH:
- R255.6
- Code:
- A
References:
［1］曾小峰,朱松林,谭爱春,等.我国类风湿关节炎疾病负担和生存质量研究的系统评价［J］.中国循证医学杂志,2013,13(3):300-307.
［2］SINGH JA.Treatment guidelines in rheumatoid arthritis［J］.Rheumatic Diseases Clinics of North America,2022,48(3):679-689.
［3］陆婷,唐芳,马武开,等.中医药介导PI3K/AKT信号通路在类风湿关节炎中的机制探讨［J］.风湿病与关节炎,2023,12(10):43-46,55.
［4］王帆帆,刘健,方妍妍,等.中医药治疗可降低类风湿关节炎合并血小板升高患者再入院的风险:一项匹配队列研究［J］.南方医科大学学报,2023,43(9):1548-1557.
［5］禄成龙,宫玉锁,刘建平,等.中医药介导OPG/RANK/RANKL信号通路防治类风湿关节炎的研究进展［J］.数理医药学杂志,2023,36(9):697-707.
［6］丁久力,郭小静,刘维,等.基于络病理论探讨虫类药物在类风湿关节炎中的应用［J］.北京中医药大学学报,2023,46(11):1499-1504.
［7］时一鸣,姜平,蒋恬,等.基于网络药理学探讨益肾蠲痹丸治疗类风湿关节炎的作用机制［J］.上海中医药杂志,2023,57(8):68-73.
［8］段盈竹,张欢,于游,等.基于CHARLS数据库我国中老年人心血管疾病对类风湿关节炎的影响探析其中医药治疗新途径［J］.中华中医药学刊,2023,41(12):165-168.
［9］李达,姜泉,徐浩东,等.基于络病理论之中医药防治类风湿关节炎证治研究［J］.辽宁中医药大学学报,2024,26(1):150-153.
［10］陈甜甜,陈杰,王敏,等.基于《百年百名中医临床家从书》的类风湿关节炎与风湿性关节炎用药规律比较分析［J］.现代中医药,2020,40(6):29-35.
［11］武君珂,王玉玉,张芳芳,等.基于“同病异治” 原则治疗类风湿性关节炎中药的研究进展［J］.天津中医药,2023,40(6):790-799.
［12］国家中医药管理局.《22个专业95个病种中医诊疗方案》［M］.北京：中国中医药出版社，2010,274-276.
［13］KAWAHITO Y,MORINOBU A,KANEKO Y,et al.Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication［J］.Modern Rheumatology,2023,33(1):21-35.
［14］VALERIO V,KWOK M,LOEWEN H,et al.Systematic review of recommendations on the use of methotrexate in rheumatoid arthritis［J］.Clinical Rheumatology,2021,40(4):1259-1271.
［15］FLEISCHMANN R,HARAOUI B,BUCH MH,et al.Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate［J］.Rheumatology and Therapy,2023,10(2):375-386.
［16］YAJIMA N,KAWAGUCHI T,TAKAHASHI R,et al.Adherence to methotrexate and associated factors considering social desirability in patients with rheumatoid arthritis:a multicenter cross-sectional study［J］.BMC Rheumatology,2022,6(1):75.
［17］TANAKA Y.Subcutaneous injection of methotrexate:advantages in the treatment of rheumatoid arthritis［J］.Modern Rheumatology,2023,33(4):633-639.
［18］NAGAFUCHI H,GOTO Y,KIYOKAWA T,et al.Reasons for discontinuation of methotrexate in the treatment of rheumatoid arthritis and challenges of methotrexate resumption:a single-center,retrospective study［J］.Egyptian Rheumatology and Rehabilitation,2022,49(1):63.
［19］RUBIO-ROMEROE,DíAZ-TORN-C,MORENO-MART-NEZ MJ,et al.Methotrexate treatment strategies for rheumatoid arthritis:a scoping review on doses and administration routes［J］.BMC Rheumatology,2024,8(1):11.
［20］DUQUESNE J,BOUGET V,COURNDE PH,et al.Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis［J］.Rheumatology,2023,62(7):2402-2409.
［21］KIM JW,CHUNG SW,PYO JY,et al.Methotrexate,leflunomide and tacrolimus use and the progression of rheumatoid arthritis-associated interstitial lung disease［J］.Rheumatology,2023,62(7):2377-2385.
［22］BRAUN J,KSTNER P,FLAXENBERG P,et al.Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis:results of a six-month,multicenter,randomized,double-blind,controlled,phase IV trial［J］.Arthritis and Rheumatism,2008,58(1):73-81.
［23］石欣,胡红,陈君.归脾汤加味联合来氟米特治疗类风湿关节炎疗效观察［J］.中医临床研究,2020,12(14):90-93.
［24］张仕玉,镇水清,镇树清.马钱子木瓜丸和木瓜风湿丸治疗湿热型痛风的临床研究［J］.中医药临床杂志,2017,29(4):543-545.
［25］张仕玉,镇水清.马钱子木瓜丸和木瓜风湿丸治疗湿热型复发性风湿病32例疗效观察［J］.时珍国医国药,2016,27(8):1933-1934.
［26］张仕玉,镇水清,镇树清.木瓜风湿丸联合西药治疗湿热痹阻型类风湿关节炎100例疗效观察［J］.中国中西医结合杂志,2018,38(11):1336-1339.
［27］ZHAO ZX,HUA ZL,LUO XY,et al.Application and pharmacological mechanism of methotrexatein rheumatoid arthritis［J］.Biomedecine & Pharmacotherapie,2022,150:113074.
［28］HAMED KM,DIGHRIRI IM,BAOMAR AF,et al.Overview of methotrexate toxicity:a comprehensive literature review［J］.Cureus,2022,14(9):e29518.
［29］TORRES RP,SANTOS FP,BRANCO JC.Methotrexate:implications of pharmacogenetics in the treatment of patients with Rheumatoid Arthritis［J］.ARP Rheumatology,2022,1(3):225-229.
［30］ZANETTI A,ZAMBON A,SCIR-CA,et al.Impact of rheumatoid arthritis and methotrexate on pregnancy outcomes:retrospective cohort study of the Italian Society for Rheumatology［J］.RMD Open,2022,8(2):e002412.
Memo
基金项目：湖北省卫健委中医药科研项目青年人才项目(ZY2021Q046)